Real-World Tolerability of Adjuvant Capecitabine in TNBC

Created using ChatSlide

This study investigates the recurrence of high-risk triple-negative breast cancer (TNBC) in patients with residual disease, focusing on the real-world tolerability of capecitabine. An international retrospective cohort of 598 non-pathological complete response (non-pCR) patients was analysed. Findings reveal that hand-foot syndrome (HFS) was the most common toxicity, affecting 36.5% of patients, with dose reductions and treatment discontinuations noted. HFS was identified as a significant...